Stocks and Investing Stocks and Investing
Mon, April 27, 2015
Fri, April 24, 2015
Thu, April 23, 2015

Matthew Luchini Initiated (BLUE) at Buy and Held Target at $160 on, Apr 23rd, 2015


Published on 2024-10-25 08:27:35 - WOPRAI, Matthew Luchini
  Print publication without navigation


Matthew Luchini of BMO Capital, Initiated "bluebird bio, Inc." (BLUE) at Buy and Held Target at $160 on, Apr 23rd, 2015.

Matthew has made no other calls on BLUE in the last 4 months.



There are 2 other peers that have a rating on BLUE. Out of the 2 peers that are also analyzing BLUE, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Matthew


  • Jason McCarthy of "Maxim Group" Initiated at Strong Buy and Held Target at $190 on, Wednesday, April 22nd, 2015
  • Cory Kasimov of "JP Morgan" Maintained at Buy with Increased Target to $117 on, Thursday, February 26th, 2015

Contributing Sources